Stay updated on 89Zr-DFO-daratumumab Imaging in Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the 89Zr-DFO-daratumumab Imaging in Multiple Myeloma Clinical Trial page.

Latest updates to the 89Zr-DFO-daratumumab Imaging in Multiple Myeloma Clinical Trial page
- Check6 days agoChange DetectedThe page now renders a 403 Forbidden error, blocking access to the study record. The 403 content replaces the prior study details and navigation, indicating an access restriction rather than a substantive content update.SummaryDifference18%

- Check13 days agoChange DetectedThe study overview no longer shows the condition 'Multiple myeloma'. The 'related topics' section, including the 'MedlinePlus Genetics' entry, is removed.SummaryDifference0.2%

- Check20 days agoChange DetectedThe related topics section now includes links for Multiple myeloma and MedlinePlus Genetics, expanding navigational context for readers. This is a minor enhancement to the page's contextual information rather than a change to core study details.SummaryDifference0.2%

- Check27 days agoChange DetectedThe page now shows a revised tag of v3.6.6, replacing the previous v3.6.5, signaling a newer version of the page in the system.SummaryDifference0.1%

- Check41 days agoChange DetectedThe study page now includes sponsor and investigator information, as well as additional links and expanded study content (protocol and statistical plan, imaging plans, eligibility criteria, and related terminology), enriching the contextual information and navigation of the record. This broader set of metadata reflects a more complete and accessible study documentation.SummaryDifference48%

- Check48 days agoChange DetectedThe page now shows Revision: v3.6.5 and the previous Revision: v3.6.4 has been removed. This reflects a version update to the page's content.SummaryDifference0.1%

Stay in the know with updates to 89Zr-DFO-daratumumab Imaging in Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the 89Zr-DFO-daratumumab Imaging in Multiple Myeloma Clinical Trial page.